IO Biotech, Inc.
IO Biotech, Inc. (IOBT) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 33 transactions totaling $75.9M, demonstrating a bullish sentiment with $72.1M in net insider flow. The most recent transaction on Jul 26, 2024 involved a sale of 23,478 shares valued at $30.8K.
IOBT Insider Activity Summary
Who Is Buying IOBT Stock?
No significant insider buying has been recorded for IOBT in the recent period.
Who Is Selling IOBT Stock?
No significant insider selling has been recorded for IOBT in the recent period.
Is IO Biotech, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for IOBT is bullish with an Insider Alignment Score of 98/100 and a net flow of $72.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
IOBT Frequently Asked Questions
Understanding IOBT Insider Activity
Insider trading at IO Biotech, Inc. (IOBT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading IOBT stock, having executed 33 transactions in the past 90 days. The most active insider is Invest A/s Lundbeckfond (Executive), who has made 4 transactions totaling $45.0M.
Related Tools
Track IO Biotech, Inc. Insider Activity
Get notified when executives and directors at IOBT file new Form 4 transactions